● Nā maʻi hanu
-
Influenza A Virus H3N2 Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka maʻi influenza A H3N2 nucleic acid i loko o nā laʻana o ka nasopharyngeal swab kanaka.
-
ʻO ka maʻi maʻi maʻi maʻi maʻi i hoʻomaloʻo ʻia i ka paʻukū/ka maʻi maʻi influenza B nucleic acid
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A (IFV A) a me ka maʻi maʻi influenza B (IFV B) RNA i nā laʻana o ka nasopharyngeal swab kanaka.
-
ʻEono Respiratory Pathogens Nucleic Acid i hoʻomaloʻo ʻia
Hoʻohana ʻia kēia huahana no ka in vitro qualitative detection of respiratory syncytial virus (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III) a me Mycoplasma pneumoniae (MP) nucleic acids in human nasopharyngeal swab samples.
-
ʻEwalu ʻano o nā maʻi hoʻomake hanu
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka maʻi influenza A (IFV A), ka maʻi maʻi influenza B (IFVB), ka maʻi hanu syncytial (RSV), adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ka maʻi Parainfluenza (PIV) a me ka Mycoplasma pneumoniae nabharynges o ka nucleopharyngeal nucleopharyngeal (MP) swab samples.
-
ʻEiwa ʻano o nā maʻi hoʻomake hanu
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A (IFV A), ka maʻi influenza B (IFVB), ka coronavirus hou (SARS-CoV-2), ka maʻi hanu syncytial (RSV), adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (RhV) a me ka maʻi virus parainfluenza (PIV) a me ka maʻi maʻi maʻi I/II/III. nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Influenza A Virus/ Influenza B Virus
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka maʻi influenza A a me ka maʻi influenza B RNA i loko o nā laʻana oropharyngeal swab kanaka.
-
ʻEono ʻAi ʻAi ʻAha
Hoʻohana ʻia kēia kit no ka ʻike qualitative o respiratory syncytial virus (RSV), adenovirus (Adv), human metapneumovirus (hMPV), rhinovirus (Rhv), parainfluenza virus type I/II/III (PIVI/II/III), a me Mycoplasma pneumoniae (MP) nucleic acids i loko o nā laʻana oropharyngeal swab samples.
-
11 Nā ʻano o ka maʻi maʻi hanu
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.
-
14 Nā ʻano maʻi hanu i hui ʻia
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o nā pathogens hanu i loko o ka waikawa nucleic i unuhi ʻia mai nā laʻana oropharyngeal swab kanaka.
Hoʻohana ʻia kēia kumu hoʻohālike no ka ʻike qualitative o 2019-nCoV, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā mea hoʻohālike swab oropharyngeal kanaka.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A, ka maʻi influenza B, ka maʻi hanu syncytial, adenovirus, ka rhinovirus kanaka a me ka mycoplasma pneumoniae nucleic acids i loko o nā swabs nasopharyngeal kanaka a me nā mea hoʻohālike oropharyngeal swab. Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen respiratory, a hāʻawi i ke kumu diagnostic molecular auxiliary no ka ʻike a me ka mālama ʻana i nā maʻi pathogen respiratory.
-
SARS-CoV-2/influenza A/influenza B
He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka maʻi influenza B. Hiki ke hoʻohana ʻia i ka poʻe maʻi a me ka qualitative influenza detection a me ka qualitative influenza-CoV detection a me ka qualitative influenza. a me ka influenza B nucleic acid i loko o ka nasopharyngeal swab a me ka oropharyngeal swab samples o ka maʻi Coronavirus hou ma nā kūlana ʻē aʻe.
